Huakang Biomedical Holdings Company Limited announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was CNY 6.891 million compared to CNY 6.776 million a year ago. Net loss was CNY 495,000 compared to net income of CNY 1.498 million a year ago. Basic loss per share from continuing operations was CNY 0.0011 compared to basic earnings per share from continuing operations of CNY 0.0037 a year ago. For the nine months, sales was CNY 14.099 million compared to CNY 18.412 million a year ago. Net loss was CNY 6.602 million compared to net income of CNY 1.721 million a year ago. Basic loss per share from continuing operations was CNY 0.0164 compared to basic earnings per share from continuing operations of CNY 0.0043 a year ago.